Erudio Healtherudio.com
Drug
Ibrutinib trials: what clinicians said in public
No HCP commentary report on a trial studying ibrutinib yet. Erudio has found public clinician commentary on 12 clinical trials studying ibrutinib, including CAPTIVATE, CLL13, CLL17 and SYMPATICO. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CAPTIVATE NCT02910583 · Pharmacyclics LLC. DeepView → | treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma | Phase 2 | Deep | View | |||
| CLL17 NCT04608318 · German CLL Study Group DeepView → | previously untreated chronic lymphocytic leukemia | Phase 3 | Deep | View | |||
| CLL13 NCT02950051 · German CLL Study Group DeepView → | previously untreated CLL without del(17p) or TP53 mutation | Phase 3 | Deep | View | |||
| SYMPATICO NCT03112174 · Pharmacyclics LLC. DeepView → | relapsed or refractory mantle cell lymphoma | Phase 3 | Deep | View | |||
| CLL12 NCT02863718 · German CLL Study Group DeepView → | untreated Binet stage A CLL with progression risk | Phase 3 | Deep | View | |||
| E1912 NCT02048813 · National Cancer Institute (NCI) DeepView → | untreated chronic lymphocytic leukemia or small lymphocytic lymphoma | Phase 3 | Deep | View | |||
| BRUIN MCL-321 NCT04662255 · Loxo Oncology, Inc. StandardView → | previously treated, BTK inhibitor-naïve mantle cell lymphoma | Phase 3 | Standard | View | |||
| AIM NCT02471391 · Peter MacCallum Cancer Centre, Australia StandardView → | relapsed or refractory mantle cell lymphoma | Phase 2 | Standard | View | |||
| A041202 NCT01886872 · National Cancer Institute (NCI) StandardView → | previously untreated chronic lymphocytic leukemia in older patients | Phase 3 | Standard | View | |||
| A041702 NCT03737981 · National Cancer Institute (NCI) FocusedView → | Not given | Phase 3 | Focused | View | |||
| NCT01776840 NCT01776840 · Janssen Research & Development, LLC FocusedView → | newly diagnosed mantle cell lymphoma | Phase 3 | Focused | View | |||
| GLOW NCT03462719 · Janssen Research & Development, LLC FocusedView → | Not given | Phase 3 | Focused | View | |||